JP Morgan Chase’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

JP Morgan Chase’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-46,500	Closed	-$781K	–	6012
2018 Q3	$781K	Buy	+46,500	New	+$1.01M	﹤0.01%	4051

JP Morgan Chase's SPPI Position: Q3 2023 in Review

JP Morgan Chase sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 3,924 shares — an estimated $3.77K sold.

JP Morgan Chase first reported a position in SPPI in Q2 2013 and held it in 31 quarters. The position peaked at $5.46M in Q4 2017. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

JP Morgan Chase reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
JP Morgan Chase sold 3,924 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $3.77K.
JP Morgan Chase first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 31 quarters.
JP Morgan Chase's Spectrum Pharmaceuticals Inc position peaked at $5.46M in Q4 2017.
0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.